The α2-Adrenoceptor Antagonist Idazoxan Reverses Catalepsy Induced by Haloperidol in Rats Independent of Striatal Dopamine Release: Role of Serotonergic Mechanisms-Reference-Cited by-同舟云学术

The α2-Adrenoceptor Antagonist Idazoxan Reverses Catalepsy Induced by Haloperidol in Rats Independent of Striatal Dopamine Release: Role of Serotonergic Mechanisms

Published:2002-11-25 Issue:5 Volume:28 Page:872-879
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol

Author:

Invernizzi Roberto W,Garavaglia Claudio,Samanin Rosario

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/1300119.pdf

Reference49 articles.

1. Ahlenius S, Hillegaart V (1986). Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effect produced by pre- and postsynaptic inhibition of dopaminergic neurotransmission. Pharmacol Biochem Behav 24: 1409–1415.

2. Al-Shabibi UMH, Dogget NS (1978). On the central noradrenergic mechanism involved in haloperidol-induced catalepsy in the rat. J Pharm Pharmacol 30: 529–531.

3. Baik J-H, Picetti R, Saiardi A, Thiriet G, Dierich A, Depaulis A et al (1995). Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377: 424–428.

4. Bezard E, Brefel C, Tison F, Peyro-Saint-Paul H, Ladure P, Rascol O et al (1999). Effect of the α2-adrenoceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey. Prog Neuro-Psychopharmacol Biol Psychiatry 23: 1237–1246.

5. Breese GR, Cooper BR (1975). Behavioral and biochemical interaction of 5,7-dihydroxytryptamine with various drugs when administered intracisternally to adult and developing rats. Brain Res 98: 517–527.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined α2- and D2-receptor blockade activates noradrenergic and dopaminergic neurons, but extracellular dopamine in the prefrontal cortex is determined by uptake and release from noradrenergic terminals;Frontiers in Pharmacology;2023-08-23

2. The potent α2-adrenoceptor antagonist RS 79948 also inhibits dopamine D2 -receptors: Comparison with atipamezole and raclopride;Neuropharmacology;2022-10

3. Haloperidol‐induced catalepsy as an animal model for parkinsonism: A systematic review of experimental studies;European Journal of Neuroscience;2021-04-25

4. Advances in non-dopaminergic treatments for Parkinson's disease;Frontiers in Neuroscience;2014-05-22

5. Monitoring Extracellular Monoamines with In Vivo Microdialysis in Awake Rats: A Practical Approach;Microdialysis Techniques in Neuroscience;2012-09-29